Fractures and Osteoporosis in Patients With Diabetes With Charcot Foot

Oliver Christian Rabe1,2, Matilde Winther-Jensen2,3, Kristine Højgaard Allin2,3,4

  • 1Department of Endocrinology, Copenhagen Diabetes Foot Center (CODIF), Copenhagen, Denmark.

Diabetes Care
|July 28, 2021
PubMed

Insights

Patients with diabetes and Charcot foot face a higher risk of fractures and osteoporosis. This study confirms an increased risk of bone complications in diabetic individuals with Charcot foot.

Area of Science:

  • Endocrinology
  • Orthopedics
  • Epidemiology

Background:

  • Charcot foot is a severe diabetic complication affecting foot and ankle bones and joints.
  • The association between Charcot foot and increased risk of osteoporosis and fractures in diabetic patients remains unclear.

Purpose of the Study:

  • To investigate if diabetic patients with Charcot foot have a higher risk of fractures and/or osteoporosis compared to diabetic patients without Charcot foot.

Main Methods:

  • A nationwide, population-based, matched cohort study in Denmark (1995-2018).
  • 1,602 patients with diabetes and Charcot foot were matched with 16,296 controls.
  • Logistic regression analyzed odds ratios (ORs) for fracture and osteoporosis using Danish National Patient Register data.

Main Results:

  • Diabetic patients with Charcot foot showed increased risk for any fracture (OR 1.8), lower-leg fracture (OR 2.4), foot fracture (OR 2.9), and osteoporotic fracture (OR 1.3).
  • A higher risk of osteoporosis was observed in patients with Charcot foot (OR 1.3).

Conclusions:

  • Diabetic patients diagnosed with Charcot foot exhibit an elevated risk for fractures.
  • Individuals with diabetes and Charcot foot also face an increased likelihood of developing osteoporosis.
Abstract

Related Concept Videos

Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
4.4K
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
92
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.2K
Fractures: Bone Repair01:27

Fractures: Bone Repair

Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
4.1K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
193
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.3K